Improving speech recovery after stroke using brain stimulation techniques
Optimizing speech motor learning with neuromodulation: Behavioral outcomes and neural mechanisms
This study is looking to help people who have had a stroke and have trouble speaking by using a special brain stimulation along with speech therapy to see if it can make it easier for them to communicate better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10832597 on NIH RePORTER |
What this research studies
This research aims to enhance speech recovery for individuals who have experienced a stroke and suffer from speech impairments. By combining behavioral interventions with targeted brain stimulation, the study investigates how stimulating specific brain regions can improve speech motor learning. Patients will receive transcranial direct current stimulation (tDCS) while participating in speech therapy, with the goal of strengthening the brain's speech network and improving their ability to communicate. The research will explore the neural mechanisms involved in this process to better understand how these interventions can be optimized.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced a stroke and have resulting speech impairments, particularly those diagnosed with apraxia of speech.
Not a fit: Patients who have not experienced a stroke or do not have speech impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for speech impairments, significantly improving communication abilities for stroke survivors.
How similar studies have performed: Previous research has shown promising results using neuromodulation techniques like tDCS to enhance motor learning, suggesting potential success for this approach in speech recovery.
Where this research is happening
New York, United States
- New York University — New York, United States (Active)
Researchers
- Principal investigator: Buchwald, Adam — New York University
- Study coordinator: Buchwald, Adam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.